Cargando…
Pooled allogeneic faecal microbiota MaaT013 for steroid-resistant gastrointestinal acute graft-versus-host disease: a single-arm, multicentre phase 2 trial
BACKGROUND: Failure of gastrointestinal acute graft-versus-host disease (GI-aGvHD) to respond to steroid therapy is associated with limited further therapeutic options. We aimed to assess the safety and efficacy of the first-in-human use of the pooled allogeneic faecal microbiota, MaaT013, for the t...
Autores principales: | Malard, Florent, Loschi, Michael, Huynh, Anne, Cluzeau, Thomas, Guenounou, Sarah, Legrand, Faezeh, Magro, Leonardo, Orvain, Corentin, Charbonnier, Amandine, Panz-Klapuch, Marta, Desmier, Deborah, Mear, Jean-Baptiste, Cornillon, Jérôme, Robin, Christine, Daguindau, Etienne, Bilger, Karin, Vehreschild, Maria J.G.T., Chevallier, Patrice, Labussière-Wallet, Hélène, Mediavilla, Clémence, Couturier, Marie-Anne, Bulabois, Claude-Eric, Camus, Vincent, Chantepie, Sylvain, Ceballos, Patrice, Gaugler, Béatrice, Holler, Ernst, Doré, Joël, Prestat, Emmanuel, Gasc, Cyrielle, Plantamura, Emilie, Mohty, Mohamad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10466244/ https://www.ncbi.nlm.nih.gov/pubmed/37654670 http://dx.doi.org/10.1016/j.eclinm.2023.102111 |
Ejemplares similares
-
High gastrointestinal microbial diversity and clinical outcome in graft-versus-host disease patients
por: Malard, Florent, et al.
Publicado: (2018) -
Spectacular and Prompt Response to Extracorporeal Photopheresis for Refractory Cutaneous Chronic Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation: A Case Report
por: Spałek, Adrianna, et al.
Publicado: (2022) -
Development and validation of Malaysia Medication Adherence Assessment Tool (MyMAAT) for diabetic patients
por: Hatah, Ernieda, et al.
Publicado: (2020) -
Outcome after allogeneic stem cell transplantation with haploidentical versus HLA-matched donors in patients with higher-risk MDS
por: Michel, Claire, et al.
Publicado: (2023) -
Clofarabine/busulfan-based reduced intensity conditioning regimens provides very good survivals in acute myeloid leukemia patients in complete remission at transplant: a retrospective study on behalf of the SFGM-TC
por: Le Bourgeois, Amandine, et al.
Publicado: (2018)